Don't Just Read the Abstract

By Richard Buka

Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.

Image by Richard Buka

Category: Health & Fitness

Open in Apple Podcasts


Open RSS feed


Open Website


Rate for this podcast

Subscribers: 1
Reviews: 0
Episodes: 34

Description

Want to stay up-to-date on the very latest developments in non-malignant haematology? Don't have the time or skills to critically appraise important papers? Join Pip and Rich, two haematology doctors on a journey of learning and discovery. Each episode, they will discuss a seminal trial, critically appraise the paper, interview a study author, and discuss the implications of the trial on clinical practice with a subject expert. CPD credits are available from RCPath. The podcast is sponsored by Sobi as a hands-off educational grant. Sobi have no editorial input whatsoever.


This podcast helps you to go beyond the abstract, delving deep into the methods, results, subanalyses, and implications. Interviews with authors gives a real-life perspective on the running of a clinical trial allowing explanations of why they did what they did and good honest discussion on limitations and how they might do it differently next time.


Hosted on Acast. See acast.com/privacy for more information.


Episode Date
Using AI to identify hospital acquired thrombosis
May 26, 2026
Apixaban vs rivaroxaban: the trial we've all been waiting for
Mar 17, 2026
ENERGIZE: Mitapivat in thalassaemia
Feb 27, 2026
Ianalumab for ITP: VAYHIT2
Feb 10, 2026
Highlights of 2025 (Episode 2)
Jan 09, 2026
Highlights of 2025 (Episode 1)
Dec 26, 2025
Does anyone care about idiopathic and secondary polycythaemia? We do!
Dec 09, 2025
Rebalancing haemostasis with marstacimab - an discussion about the BASIS trial
Nov 13, 2025
BSH President Dr Sue Pavord: An Interview
Oct 29, 2025
DJRTA Newsletter #2
Oct 22, 2025
Intervention for Intermediate-High Risk PE
Oct 15, 2025
Introducing the DJRTA Newsletter
Oct 07, 2025
HI-PRO: Apixaban for Extended Treatment of Provoked Venous Thromboembolism
Sep 30, 2025
API-CAT: Author interview with Prof. Isabelle Mahé
Sep 15, 2025
API-CAT: Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism
Jul 21, 2025
LUNA3: Rilzabrutinib for ITP
Jul 06, 2025
Haematology in The Gambia with Dr Megan Kell
Jun 12, 2025
Efanesoctocog alfa for severe haemophilia A: expert perspective with Dr Susie Shapiro
May 30, 2025
Efanesoctocog alfa - a very long half life factor VIII
May 16, 2025
BSH Day 2
Apr 28, 2025
BSH Day 1
Apr 27, 2025
Preview of BSH 2025: a focus on medical haematology
Apr 18, 2025
PEERLESS - Management of Acute Intermediate-Risk PE
Apr 04, 2025
AI powered ultrasound for DVT - an interview with CEO of ThinkSono, Fouad Al Noor
Mar 21, 2025
Iptacopan for PNH
Mar 07, 2025
Plasma exchange free treatment of TTP: Author Discussion
Feb 21, 2025
Plasma exchange free treatment of TTP
Jan 31, 2025
Exa-cel for severe sickle cell disease
Nov 12, 2024
ANNEXA-I: Discussion with Dr Will Lester
Oct 02, 2024
ANNEXA-I
Aug 22, 2024
VITT, HIT, and spontaneous syndromes
May 26, 2024
Efgartigimod for ITP
Apr 16, 2024
FRAIL-AF
Mar 04, 2024
The PACER trial
Jan 21, 2024